InvestSMART

Ryman Healthcare Limited (ASX: RYM) - Share Price

Current share price for RYM : $1.810 0.03 (1.63%)+

--

RYM General Information +

ASX Code RYM
Website http://www.rymanhealthcare.co.nz
Industry/Sector Health Care Facilities
Market Cap ($M) 1,838
RYM Share Price $1.810
Day High $1.815
Day Low $1.810
Last Close $1.840
RYM Share Price Movement $0.03 ( 1.63% )
Prices as at 13:10, 9 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Ryman Healthcare Limited (RYM) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Ryman Healthcare Limited (RYM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Ryman Healthcare Limited (RYM) price-sensitive announcements

RYM - Ryman Healthcare Limited - Retail bond presentation
Ryman Healthcare Limited presents a robust financial outlook with a focus on strategic imp
Ryman Healthcare Limited (RYM)
9 Jun 2026 | 7:31 AM
RYM - Ryman Healthcare Limited - Indicative terms sheet
The document is an indicative terms sheet for the issuance of up to $100,000,000 fixed-rat
Ryman Healthcare Limited (RYM)
9 Jun 2026 | 7:31 AM
RYM - Ryman Healthcare Limited - Ryman launches retail bond offer
Ryman Healthcare Limited is launching a retail bond offer of up to NZ$100 million, with po
Ryman Healthcare Limited (RYM)
9 Jun 2026 | 7:30 AM
RYM - Ryman Healthcare Limited - Cleansing notice
On June 8, 2026, Ryman Healthcare Limited issued a cleansing notice for a same class offer
Ryman Healthcare Limited (RYM)
9 Jun 2026 | 7:30 AM

Ryman Healthcare Limited (RYM) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 Change in substantial holding 1 Jul 2026 3:09PM $1.860 $1.810 fallen by 2.69%
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 Change in substantial holding 1 Jul 2026 3:08PM $1.860 $1.810 fallen by 2.69%
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 Ryman Healthcare Limited - Proxy Form 2026 26 Jun 2026 7:30AM $1.870 $1.810 fallen by 3.21%
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 Ryman Healthcare Limited - Notice of Meeting 2026 26 Jun 2026 7:30AM $1.870 $1.810 fallen by 3.21%
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 ASX Listing Rule 1.15.3 24 Jun 2026 7:30AM $1.840 $1.810 fallen by 1.63%
Ryman Healthcare Limited (RYM)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
Health Care $1,838 Capital Change Notice - RYM010 Bonds 22 Jun 2026 1:44PM $1.865 $1.810 fallen by 2.95%

RYM Financial Summary

Year to Mar NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A C2 -$5.80 0.00% 0.00 0.00 0.00% 0.0%

RYM Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2026 A 2026 A 2026 A
Regis Healthcare Limited (REG) $1,987M -6.7687 0.0813 0.2360 37.0977 34.3081 27.7567 2.47% 2.69% 3.17%
Ramsay Health Care Limited (RHC) $9,937M 0.2153 -0.2767 0.4017 27.4012 37.8861 27.0279 1.86% 1.97% 2.42%
Ryman Healthcare Limited (RYM) $1,869M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

RYM Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.55 0.00
Market 0.28 13.00 1.14 0.58
Sector 0.68 23.20 1.59 2.54

RYM Directors

Name Position Start Date
Mr Dean Ross Hamilton Non-Executive Chairman, Non-Executive Director 1 Jan 0001
Mr James Bruce Miller Non-Executive Director 1 Jan 0001
Ms Paula Jeffs Non-Executive Director 1 Jan 0001
Mr David Pitman Non-Executive Director 1 Jan 0001
Ms Kathryn(Kate) Marian Munnings Non-Executive Director 1 Jan 0001
Mr Scott Pritchard Non-Executive Director 1 Jan 0001
Mr Hamish Rumbold Non-Executive Director 1 May 2026

Ryman Healthcare Limited (RYM) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
15 Dec 2025 HAMILTON, Dean Buy Direct Shares 7,253 $2.940 $21,323.820

See all changes in directors' interest & trades for Ryman Healthcare Limited (RYM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

RYM Management

Name Position
Richard Stephenson Chief Development and Property Officer
Rachna Gandhi Chief Enterprise Strategy, Systems and Governance Office
Naomi James Chief Executive Officer
Matt Prior Chief Financial Officer
Marsha Cadman Chief Operating Officer
Di Walsh Chief People and Safety Officer
Marie Bonnemaison Chief Transformation and Corporate Development Officer
Morgan Powell Company Secretary

RYM Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Ryman Healthcare Limited (RYM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
79,223,802 (7.80%) FirstCape Group Limited
44,042,464 (6.41%) Forsyth Barr Investment Management Limited

RYM Calendar of Events

Date Event
04 June 2027 Report (Annual)
25 May 2027 Report (Prelim)
26 November 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.